OPRX OptimizeRx Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: OPRX

Price (delayed)

$7.71

Market cap

$145.23M

P/E Ratio

32.13

Dividend/share

N/A

EPS

$0.24

Enterprise value

$140.61M

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 38
Relative Valuation: Rel. Valuation: 80
Relative Profitability: Rel. Profitability: 83

OptimizeRx provides trailblazing technology that fosters care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the healthcare journey. With the ability to synchronize messaging across ...

Highlights
OptimizeRx's quick ratio has surged by 111% YoY
The debt has declined by 33% year-on-year and by 18% since the previous quarter
The net income has surged by 147% year-on-year but it has declined by 33% since the previous quarter
OptimizeRx's EPS has soared by 144% YoY but it has decreased by 33% from the previous quarter
OPRX's revenue is down by 8% since the previous quarter and by 6% year-on-year
Sector: Healthcare
Industry: Health Information Services
Website: http://www.optimizerx.com
Peers: LPSN CXDO SOHU

Key stats

What are the main financial stats of OPRX

OPRX stock price

How has the OptimizeRx stock price performed over time
Intraday
-3.14%
1 week
-11.58%
1 month
15.77%
1 year
-52.23%
YTD
-37.11%
QTD
34.79%

Financial performance

How have OptimizeRx's revenue and profit performed over time
Revenue
$98.65M
Gross profit
$72.24M
Operating income
$10.93M
Net income
$4.6M
Gross margin
73.2%
Net margin
4.7%
The net margin has surged by 150% year-on-year but it has declined by 27% since the previous quarter
The net income has surged by 147% year-on-year but it has declined by 33% since the previous quarter
The operating income has contracted by 23% from the previous quarter
OPRX's operating margin is down by 16% since the previous quarter

Price vs fundamentals

How does OPRX's price correlate with its fundamentals

Growth

What is OptimizeRx's growth rate over time

Valuation

What is OptimizeRx stock price valuation
P/E
32.13
P/B
1.1
P/S
1.47
EV/EBIT
12.27
EV/EBITDA
8.93
EV/Sales
1.43
OptimizeRx's EPS has soared by 144% YoY but it has decreased by 33% from the previous quarter
The price to book (P/B) is 61% less than the 5-year quarterly average of 2.8 and 35% less than the last 4 quarters average of 1.7
OPRX's equity is up by 10% year-on-year
The stock's P/S is 72% below its 5-year quarterly average of 5.2 and 23% below its last 4 quarters average of 1.9
OPRX's revenue is down by 8% since the previous quarter and by 6% year-on-year

Efficiency

How efficient is OptimizeRx business performance
The return on assets has surged by 146% year-on-year but it has declined by 33% since the previous quarter
The return on equity has surged by 142% year-on-year but it has declined by 35% since the previous quarter
The ROIC is down by 20% since the previous quarter
OptimizeRx's ROS has decreased by 16% from the previous quarter

Dividends

What is OPRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPRX.

Financial health

How did OptimizeRx financials performed over time
The current ratio has soared by 117% YoY and by 3.9% from the previous quarter
OptimizeRx's quick ratio has surged by 111% YoY
The debt is 85% smaller than the equity
OPRX's debt to equity is down by 38% year-on-year and by 17% since the previous quarter
The debt has declined by 33% year-on-year and by 18% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.